Stockscreener 앱 받기
0.10%
전일 마감가:
$25.01
열려 있는:
$25.03
하루 거래량:
739.78K
Relative Volume:
0.02
시가총액:
$141.84B
수익:
$63.63B
순이익/손실:
$8.03B
주가수익비율:
17.75
EPS:
1.41
순현금흐름:
$9.84B
1주 성능:
-4.51%
1개월 성능:
-4.18%
6개월 성능:
-14.03%
1년 성능:
-9.97%
1일 변동 폭
$25.01
$25.08
1주일 범위
$24.83
$26.52
52주 변동 폭
$24.48
$31.54
화이자 Stock (PFE) Company Profile
명칭
Pfizer Inc
전화
(212) 733-2323
주소
66 HUDSON BOULEVARD EAST, NEW YORK, NY
PFE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
25.03 | 141.84B | 63.63B | 8.03B | 9.84B | 1.41 |
|
LLY
Lilly Eli Co
|
822.00 | 738.00B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
203.44 | 358.61B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
163.65 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
NVO
Novo Nordisk Adr
|
70.16 | 311.44B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
MRK
Merck Co Inc
|
88.30 | 221.28B | 64.17B | 17.12B | 18.10B | 6.73 |
화이자 Stock (PFE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-25 | 재개 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-03-22 | 다운그레이드 | Argus | Buy → Hold |
| 2024-02-23 | 개시 | Guggenheim | Buy |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-10-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-17 | 재확인 | JP Morgan | Neutral |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-06-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | 개시 | Jefferies | Hold |
| 2023-02-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-01-03 | 재확인 | Bernstein | Mkt Perform |
| 2021-12-20 | 재확인 | Cowen | Outperform |
| 2021-12-17 | 개시 | Goldman | Neutral |
| 2021-12-13 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-12-16 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | 재개 | Goldman | Neutral |
| 2020-11-10 | 재개 | Bernstein | Mkt Perform |
| 2020-10-12 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-16 | 개시 | SVB Leerink | Mkt Perform |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-27 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-07-30 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | 재개 | Morgan Stanley | Overweight |
| 2019-02-20 | 재개 | Citigroup | Neutral |
| 2019-01-31 | 업그레이드 | Argus | Hold → Buy |
| 2019-01-31 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-01 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
모두보기
화이자 주식(PFE)의 최신 뉴스
Minoxidil Market Set to Witness Significant Growth by 2025-2032 - openPR
Pfizer leader who launched Covid vaccine gives small pharma a try - The Business Journals
Senator Slams Pfizer (PFE) for “Biggest Tax-Dodging Scheme in Pharma History” - Markets Insider
Pfizer: Value Play Or Past Its Prime? - Barchart
Pfizer: Value Play or Past Its Prime? - The Globe and Mail
Pfizer Tops Pharma Tax Avoidance, Senate Dems Say - Law360
US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports - Reuters
Pfizer ran what could be the largest tax dodging scheme among Big Pharma: Senator - Seeking Alpha
Sector Update: Health Care - Marketscreener.com
Pfizer's Bold Tax Maneuver Sparks Controversy - Finimize
Pfizer Avoided Billions in Taxes on Sales, Democrats Say (2) - Bloomberg Tax
UC San Diego Moores Cancer Center Receives $1M Donation from Pfizer for Early Cancer Detection | Newswise - Newswise
May 9th Options Now Available For Pfizer (PFE) - Nasdaq
GSK accuses Pfizer of delaying Covid vaccine result until after US election - Yahoo
Is Pfizer Inc.'s (NYSE:PFE) Recent Price Movement Underpinned By Its Weak Fundamentals? - Yahoo Finance
Why Pfizer Is My Largest Healthcare Position - MSN
Citi maintains Pfizer stock Neutral with $27 target amid probe By Investing.com - Investing.com Australia
Citi maintains Pfizer stock Neutral with $27 target amid probe - Investing.com
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks - Yahoo Finance
Feds probe tip that Pfizer delayed announcing COVID vaccine’s success until after 2020 election: report - New York Post
Exclusive | U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine - The Wall Street Journal
Market Today: Pfizer Faces Investigation, Microsoft Scales Back Data Centers - GuruFocus.com
Here's Why Pfizer (PFE) Fell More Than Broader Market - Yahoo Finance
Pfizer Shares Are Down Today: What's Going On? - Benzinga
Pfizer shares dip amid U.S. vaccine probe reports By Investing.com - Investing.com Australia
Pfizer shares dip amid U.S. vaccine probe reports - Investing.com
Pfizer drops after report on U.S. probe related to its COVID vaccine success - Seeking Alpha
Pfizer falls after report says US probing tip about timing of COVID vaccine - TradingView
US Prosecutors Investigate Tip on Pfizer Vaccine - Marketscreener.com
US Prosecutors Investigate Tip on Pfizer Vaccine, Wall Street Journal Reports - Marketscreener.com
US Prosecutors Probe Tip About Timing Of Pfizer VaccineWSJ - Marketscreener.com
Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts By Investing.com - Investing.com South Africa
Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com
Pfizer’s CX Vision: Powered by People, Fueled by Data - CMSWire
ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program - Quantisnow
Pfizer Stock Slips After Report on Vaccine Timing Probe - The Wall Street Journal
Drug Co. Wants Fed. Circ. To Undo Pfizer COVID Patent Win - Law360
Pfizer: Undervalued Defensive Play - Yahoo Finance
Pfizer Is Trading As If It's 2009 Again (NYSE:PFE) - Seeking Alpha
Which is the Healthiest Investment: Merck or PfizerF.A.S.T. GraphsCommentaries - Advisor Perspectives
Broadcom and Crown Castle in the Box have been highlighted as Zacks Bull and Bear of the Day - TradingView
USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars? - Crowell & Moring LLP
Is Pfizer (PFE) The Best Affordable Stock To Buy According To Hedge Funds? - Insider Monkey
Pfizer Is A Dirt-Cheap High-Yield Stock, But Is It A Buy? - Barchart
China touted its business potential at a meeting with Apple, Pfizer and other US companies - Українські Національні Новини
Pfizer Is a Dirt-Cheap High-Yield Stock, But Is It a Buy? - Zacks Investment Research
Pfizer Inc. (PFE) Stock: Is This Healthcare Giant the Bargain of 2025? - MoneyCheck
Epinephrine Market Is Booming Worldwide 2025-2032 | Pfizer, - openPR
Pfizer Inc. - Britannica
China Courts Apple, Pfizer, Eli Lilly Amid US Pressure, Vice Premier Says Beijing 'Will Continue To Improve The Business Environment' - MSN
China reassures Apple, Pfizer, Cargill, others of business potential - TradingView
화이자 (PFE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.73%
0.24%
자본화:
|
볼륨(24시간):